|
Federal update
|
|
|
Even with Congress on its August recess, NPF advocacy continues to engage with lawmakers.
- In a letter to the Senate Appropriation Committee chairs, we reiterated our request for $1 million to support psoriatic disease research at the Centers for Disease Control.
- NPF joined other patient advocacy groups to urge the House Committee on Energy & Commerce leadership to advance legislation to lower out-of-pocket costs by creating an out-of-pocket cap for Medicare Part D beneficiaries.
Momentum continues to build behind the Safe Step Act (H.R. 2279) to protect patients from potentially harmful "fail first" step therapy protocols - to date, we have commitments from over 80 members from both parties in the House of Representatives.
Now is the time to share your step therapy story. Please take a moment to weigh-in with your federal lawmakers and tell them why protection from step therapy tactics is important to you.
|
|
|
Stay informed
|
|
|
|
|
|
Psoriasis shouldn't stop you from living your life. With today's treatment options, so much is possible. Wearing shorts. Hitting the beach. Hiking the trail that's been calling your name.
|
|
|
|